Patents by Inventor Eyal Levit

Eyal Levit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF DIABETES MELLITUS
    Publication number: 20230203183
    Abstract: The present invention provides a method of treating insulin-dependent diabetes mellitus in a subject, comprising administering to the subject a therapeutically effective amount of a Janus kinase inhibitor, or a pharmaceutically acceptable salt or ester thereof, or a therapeutically effective amount of intravenous immunoglobulin, or a therapeutically effective amount of a therapeutic agent that destroys B lymphocytes, or a combination thereof. The present invention also provides kits containing the same.
    Type: Application
    Filed: November 15, 2022
    Publication date: June 29, 2023
    Inventor: Eyal Levit
  • Treatment of diabetes mellitus
    Patent number: 11498975
    Abstract: The present invention provides a method of treating insulin-dependent diabetes mellitus in a subject, comprising administering to the subject a therapeutically effective amount of a Janus kinase inhibitor, or a pharmaceutically acceptable salt or ester thereof, or a therapeutically effective amount of intravenous immunoglobulin, or a therapeutically effective amount of a therapeutic agent that destroys B lymphocytes, or a combination thereof. The present invention also provides kits containing the same.
    Type: Grant
    Filed: August 31, 2020
    Date of Patent: November 15, 2022
    Inventor: Eyal Levit
  • TREATMENT OF DIABETES MELLITUS
    Publication number: 20200399388
    Abstract: The present invention provides a method of treating insulin-dependent diabetes mellitus in a subject, comprising administering to the subject a therapeutically effective amount of a Janus kinase inhibitor, or a pharmaceutically acceptable salt or ester thereof, or a therapeutically effective amount of intravenous immunoglobulin, or a therapeutically effective amount of a therapeutic agent that destroys B lymphocytes, or a combination thereof. The present invention also provides kits containing the same.
    Type: Application
    Filed: August 31, 2020
    Publication date: December 24, 2020
    Inventor: Eyal Levit
  • Treatment of diabetes mellitus
    Patent number: 10759865
    Abstract: The present invention provides a method of treating insulin-dependent diabetes mellitus in a subject, comprising administering to the subject a therapeutically effective amount of a Janus kinase inhibitor, or a pharmaceutically acceptable salt or ester thereof, or a therapeutically effective amount of intravenous immunoglobulin, or a therapeutically effective amount of a therapeutic agent that destroys B lymphocytes, or a combination thereof. The present invention also provides kits containing the same.
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: September 1, 2020
    Inventor: Eyal Levit
  • TREATMENT OF DIABETES MELLITUS
    Publication number: 20190062447
    Abstract: The present invention provides a method of treating insulin-dependent diabetes mellitus in a subject, comprising administering to the subject a therapeutically effective amount of a Janus kinase inhibitor, or a pharmaceutically acceptable salt or ester thereof, or a therapeutically effective amount of intravenous immunoglobulin, or a therapeutically effective amount of a therapeutic agent that destroys B lymphocytes, or a combination thereof. The present invention also provides kits containing the same.
    Type: Application
    Filed: August 22, 2018
    Publication date: February 28, 2019
    Inventor: Eyal Levit